已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

An exploratory study of nimotuzumab combined with toripalimab and chemotherapy for locally advanced tonsillar cancer

医学 尼妥珠单抗 放射治疗 新辅助治疗 肿瘤科 卡铂 淋巴结 化疗 放射性武器 内科学 头颈部癌 放射科 吞咽 癌症 切除缘 外科 围手术期 颈淋巴结 病变 吞咽困难 根治性手术 手术切缘 磁共振成像 癌 病态的 T级 鼻咽癌 模式治疗法 放化疗 阶段(地层学) 耳鼻咽喉科 彭布罗利珠单抗 诱导化疗 原发性肿瘤
作者
Jingxuan Shi,Zhaoxiang Wang,Qianqian Zhao,Pengfei Liu,Leping Liang,Guanyin Chen,Dongjie He,Daqing Zhao
出处
期刊:Frontiers in Immunology [Frontiers Media]
卷期号:17: 1890647-1890647
标识
DOI:10.3389/fimmu.2026.1890647
摘要

Background: Neoadjuvant immunotherapy/targeted therapy combined with chemotherapy shows encouraging activity for oropharyngeal squamous cell carcinoma (OPSCC). However, evidence specific to tonsillar squamous cell carcinoma (TSCC) remains limited, particularly regarding the systematic relationships among radiological response, pathologic response, margin control, and voice and swallowing functional outcomes. Methods: This single-arm, single-center study included patients with pathologically confirmed TSCC diagnosed between January 2024 and June 2025. Patients received triplet neoadjuvant therapy consisting of nimotuzumab, toripalimab, nab-paclitaxel, and carboplatin every 3 weeks for 2 cycles, followed by transoral radical tonsillectomy combined with radical cervical lymph node dissection. Radiologic response was assessed using Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1) and volumetric magnetic resonance imaging (MRI). Pathologic response, margin status, perioperative safety, adjuvant treatment, and functional outcomes were evaluated. Results: Twenty patients achieved clinicopathologic downstaging after surgery. The primary-site pCR rate was 65.0%, nodal pCR was 60.0%, and overall ypT0N0 pCR was 45.0%. The objective radiological response (ORR) rate of the primary lesion was 100%, and 9 patients (45%) achieved a complete radiological response. Mean primary-tumor and dominant-node volume reductions were 76.18% and 72.59%, respectively. Both pre- and postneoadjuvant margins were negative in all patients, yielding R0 resection in all cases. Functional scores improved after neoadjuvant therapy, worsened transiently during radiotherapy, and generally recovered during follow-up. Conclusions: Nimotuzumab plus toripalimab and chemotherapy produced high radiological and pathological response rates with reliable margin control in patients with locally advanced TSCC. Postneoadjuvant boundary assessment with intraoperative pathologic verification may support individualized resection planning, but routine resection of the primary lesion and cervical lymph node dissection remain necessary. Longer follow-up and prospective validation are required to confirm these results. Clinical trial registration: https://clinicaltrials.gov/study/, identifier NCT07353723.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
人谷呀完成签到 ,获得积分10
刚刚
TopBanana完成签到 ,获得积分10
2秒前
2秒前
Biu发布了新的文献求助10
3秒前
天天快乐的应助被xc采纳,获得10
3秒前
Xieyob关注了科研通微信公众号
4秒前
5秒前
香蕉觅云的应助被richardhipower采纳,获得10
5秒前
Sylvia卉完成签到,获得积分10
5秒前
酱油发布了新的文献求助10
7秒前
xsx发布了新的文献求助10
7秒前
虹虹完成签到 ,获得积分10
8秒前
领导范儿的应助被科研通管家采纳,获得10
8秒前
深情安青的应助被科研通管家采纳,获得10
8秒前
FashionBoy的应助被科研通管家采纳,获得10
8秒前
CipherSage的应助被科研通管家采纳,获得10
8秒前
zkl完成签到,获得积分10
8秒前
9秒前
啊哦额完成签到,获得积分10
9秒前
秋风的应助被科研通管家采纳,获得20
9秒前
天天快乐的应助被科研通管家采纳,获得10
9秒前
打打的应助被科研通管家采纳,获得80
9秒前
9秒前
Hello的应助被科研通管家采纳,获得10
9秒前
9秒前
科研通AI65的应助被科研通管家采纳,获得10
9秒前
梨理完成签到 ,获得积分10
10秒前
rrr发布了新的文献求助10
10秒前
fantasy的应助被科研通管家采纳,获得30
10秒前
余香的应助被wwwww采纳,获得10
10秒前
沉默发布了新的文献求助10
10秒前
11秒前
数据线完成签到 ,获得积分10
11秒前
啊哦额发布了新的文献求助10
12秒前
13秒前
14秒前
hhh完成签到 ,获得积分10
14秒前
酷波er的应助被xc采纳,获得10
14秒前
哈哈哈发布了新的文献求助10
14秒前
万能图书馆的应助被tejing1158采纳,获得10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189722
求助须知:如何正确求助?哪些是违规求助? 9576968
关于积分的说明 21850614
捐赠科研通 7787686
什么是DOI,文献DOI怎么找? 3435771
关于科研通互助平台的介绍 2559813
邀请新用户注册赠送积分活动 2482639